发明名称 |
METHOD FOR PREDICTING THE RESPONSE TO HER2-DIRECTED THERAPY |
摘要 |
This invention provides methods for determining or predicting response to HER2-directed therapy in an individual. |
申请公布号 |
US2016091493(A1) |
申请公布日期 |
2016.03.31 |
申请号 |
US201514965402 |
申请日期 |
2015.12.10 |
申请人 |
Cell Signaling Technology, Inc. ;Ventana Medical Systems, Inc. |
发明人 |
Bacus Sarah S.;Smith Bradley L. |
分类号 |
G01N33/574 |
主分类号 |
G01N33/574 |
代理机构 |
|
代理人 |
|
主权项 |
1. A method for identifying a mammalian tumor that responds to a HER2-directed therapy, wherein the mammalian tumor overexpresses HER2, the method comprising the step of assaying a sample obtained from the mammalian tumor to detect a pattern of expression, phosphorylation or both expression and phosphorylation of one or a plurality of polypeptides consisting of:
(a) IGFR polypeptide; (b) EGFR polypeptide; (c) NDF polypeptide; (d) phosphorylated S6 ribosomal polypeptide; (e) phosphorylated AKT polypeptide; and (f) phosphorylated ERK polypeptide; wherein the detected pattern of expression, phosphorylation or both expression and phosphorylation identifies mammalian tumors that respond to a HER2-directed therapy. |
地址 |
Beverly MA US |